CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 20 | 24 | +4 |
| Shares | 967.8K | 1.18M | +207.3K (+21.4%) |
| Value | $1.44M | $828.0K | −$609.0K (−42.4%) |
New holders (7)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 147,700 | $104.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 13,642 | $10.0K | 0.00% |
| Susquehanna International Group, LLP | 11,513 | $8.00K | 0.00% |
| UBS Group AG | 3,653 | $3.00K | 0.00% |
| Global Retirement Partners, LLC | 1,000 | $1.00K | 0.00% |
| CoreCap Advisors, LLC | 800 | $1.00K | 0.00% |
| FMR LLC | 25 | $0 | 0.00% |
Sold out (3)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Virtu Financial LLC | 22,480 | $33.0K |
| HRT Financial LP | 16,531 | $24.0K |
| Sterling Financial Planning, Inc. | 600 | $1.00K |